Skip to Main Content

Author Details

Jeannie M Camarillo
and the Feinberg School of Medicine, Northwestern University
2011
27
13
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37468619Organ Mapping Antibody Panels: a community resource for standardized multiplexed tissue imaging.Nat Methods2023
38040721Author Correction: Automated imaging and identification of proteoforms directly from ovarian cancer tissue.Nat Commun2023
37838706Automated imaging and identification of proteoforms directly from ovarian cancer tissue.Nat Commun2023
37609190Epi-microRNA mediated metabolic reprogramming ensures affinity maturation.bioRxiv2023
37468619Organ Mapping Antibody Panels: a community resource for standardized multiplexed tissue imaging.Nat Methods2023
37460896Sperm chromatin structure and reproductive fitness are altered by substitution of a single amino acid in mouse protamine 1.Nat Struct Mol Biol2023
37838706Automated imaging and identification of proteoforms directly from ovarian cancer tissue.Nat Commun2023
37609190Epi-microRNA mediated metabolic reprogramming ensures affinity maturation.bioRxiv2023
38040721Author Correction: Automated imaging and identification of proteoforms directly from ovarian cancer tissue.Nat Commun2023
37460896Sperm chromatin structure and reproductive fitness are altered by substitution of a single amino acid in mouse protamine 1.Nat Struct Mol Biol2023
34811556Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging.Nat Methods2022
35446460Proteoform-Selective Imaging of Tissues Using Mass Spectrometry.Angew Chem Int Ed Engl2022
35443279SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.Cancer Discov2022
35947651Highly multiplexed, label-free proteoform imaging of tissues by individual ion mass spectrometry.Sci Adv2022
35413190Mapping the Proteoform Landscape of Five Human Tissues.J Proteome Res2022
34878788Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire.J Proteome Res2022
34811556Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging.Nat Methods2022
35084980The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells.Science2022
35443279SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.Cancer Discov2022
35446460Proteoform-Selective Imaging of Tissues Using Mass Spectrometry.Angew Chem Int Ed Engl2022
35413190Mapping the Proteoform Landscape of Five Human Tissues.J Proteome Res2022
35947651Highly multiplexed, label-free proteoform imaging of tissues by individual ion mass spectrometry.Sci Adv2022
34878788Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire.J Proteome Res2022
35084980The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells.Science2022
34268518Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire.medRxiv2021
34268518Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire.medRxiv2021
34043341New Interface for Faster Proteoform Analysis: Immunoprecipitation Coupled with SampleStream-Mass Spectrometry.J Am Soc Mass Spectrom2021
34043341New Interface for Faster Proteoform Analysis: Immunoprecipitation Coupled with SampleStream-Mass Spectrometry.J Am Soc Mass Spectrom2021
32396861Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.Cancer Cell2020
32396861Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.Cancer Cell2020
33104722Targeted detection and quantitation of histone modifications from 1,000 cells.PLoS One2020
33239043Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma.J Exp Clin Cancer Res2020
33104722Targeted detection and quantitation of histone modifications from 1,000 cells.PLoS One2020
33239043Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma.J Exp Clin Cancer Res2020
30979734Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas.Clin Cancer Res2019
31286445Coupling Fluorescence-Activated Cell Sorting and Targeted Analysis of Histone Modification Profiles in Primary Human Leukocytes.J Am Soc Mass Spectrom2019
30979734Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas.Clin Cancer Res2019
31286445Coupling Fluorescence-Activated Cell Sorting and Targeted Analysis of Histone Modification Profiles in Primary Human Leukocytes.J Am Soc Mass Spectrom2019
29438559Oxidative stress increases M1dG, a major peroxidation-derived DNA adduct, in mitochondrial DNA.Nucleic Acids Res2018
30192817Stability of histone post-translational modifications in samples derived from liver tissue and primary hepatic cells.PLoS One2018
29438559Oxidative stress increases M1dG, a major peroxidation-derived DNA adduct, in mitochondrial DNA.Nucleic Acids Res2018
30192817Stability of histone post-translational modifications in samples derived from liver tissue and primary hepatic cells.PLoS One2018
27978618Electrophilic Modification of PKM2 by 4-Hydroxynonenal and 4-Oxononenal Results in Protein Cross-Linking and Kinase Inhibition.Chem Res Toxicol2017
27982582Quantitative Analysis and Discovery of Lysine and Arginine Modifications.Anal Chem2017
27978618Electrophilic Modification of PKM2 by 4-Hydroxynonenal and 4-Oxononenal Results in Protein Cross-Linking and Kinase Inhibition.Chem Res Toxicol2017
27982582Quantitative Analysis and Discovery of Lysine and Arginine Modifications.Anal Chem2017
26910110Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression.Chem Res Toxicol2016
26910110Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression.Chem Res Toxicol2016
25739016Site-specific, intramolecular cross-linking of Pin1 active site residues by the lipid electrophile 4-oxo-2-nonenal.Chem Res Toxicol2015
25739016Site-specific, intramolecular cross-linking of Pin1 active site residues by the lipid electrophile 4-oxo-2-nonenal.Chem Res Toxicol2015
  • 1 - 50 of 54

Recommended Authors

Institute of Molecular and Cell Biology
Career Start Year 2014
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 2
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year 2011
Number of shared co-authors 1
Tri-Institutional PhD Program in Chemical Biology
Career Start Year 2010
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Baylor College of Medicine, USA Center for Precision Environmental Health
Career Start Year 2006
Number of shared co-authors 11
Washington University School of Medicine
Career Start Year 2005
Number of shared co-authors 2
University of Southern California
Career Start Year 2004
Number of shared co-authors 0
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 2
Howard Hughes Medical Institute, University of California San Diego
Career Start Year 2003
Number of shared co-authors 0
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2003
Number of shared co-authors 5
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 1
University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 8
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 2000
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 12
Institute of Molecular and Cell Biology
Career Start Year 2000
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 2000
Number of shared co-authors 0
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS)
Career Start Year 1999
Number of shared co-authors 1
Center for Biomedical Research Support, The University of Texas at Austin
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Salk Institute for Biological Studies
Career Start Year 1998
Number of shared co-authors 0
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 1
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University
Career Start Year 1996
Number of shared co-authors 1
Institute of Chemistry
Career Start Year 1992
Number of shared co-authors 2
Harvard Medical School
Career Start Year 1991
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 5
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 1983
Number of shared co-authors 12
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 1

Collaborators

Northwestern University
Co-authored papers 16
Northwestern University
Co-authored papers 8
Northwestern University
Co-authored papers 7
and the Feinberg School of Medicine, Northwestern University
Co-authored papers 7
and the Feinberg School of Medicine, Northwestern University
Co-authored papers 4
Northwestern University
Co-authored papers 3
Northwestern University
Co-authored papers 3
Stanford University
Co-authored papers 3
Vanderbilt University
Co-authored papers 3
Co-authored papers 3
University of California davis
Co-authored papers 3
Northwestern University
Co-authored papers 3
Northwestern University Feinberg School of Medicine
Co-authored papers 3
Stanford University School of Medicine
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 2
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 2
Stanford University School of Medicine, Stanford University
Co-authored papers 2
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 2
Co-authored papers 2
Feil Family Brain and Mind Research Institute.
Co-authored papers 2
Department of Research and Development
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
Meyer Cancer Center
Co-authored papers 2
GE Research Center
Co-authored papers 2
Center for Advanced Tissue Imaging
Co-authored papers 2
GE Global Research Center
Co-authored papers 1
Dartmouth College
Co-authored papers 1
Institut fur Pathologie
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
Co-authored papers 1